Currently out of the existing stock ratings of Justin Kim, 72 are a BUY (97.3%), 2 are a HOLD (2.7%).

Justin Kim

Work Performance Price Targets & Ratings Chart

Analyst Justin Kim, carries an average stock price target met ratio of 71.05% that have a potential upside of 58.11% achieved within 292 days. Previously, Justin Kim worked at OPPENHEIMER.

Justin Kim’s has documented 137 price targets and ratings displayed on 15 stocks. The coverage was on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on ALPN, Alpine Immune Sciences at 19-Mar-2024.

Wall Street Analyst Justin Kim

Analyst best performing recommendations are on VERA (VERA THERAPEUTICS).
The best stock recommendation documented was for VERA (VERA THERAPEUTICS) at 1/24/2024. The price target of $26 was fulfilled within 2 days with a profit of $8.98 (52.76%) receiving and performance score of 263.81.

Average potential price target upside

of $94.55 (75.59%) on ANGN (ANGION BIOMEDICA CORP).
of $20.9 (51.79%) on KD (KYNDRYL HOLDINGS).
of $19.17 (49.35%) on APLS (APELLIS PHARMACEUTICALS).

ANGN Angion Biomedica Corp APLS Apellis Pharmaceuticals AUPH Aurinia Pharmaceuticals BCRX BioCryst Pharmaceuticals CYTK Cytokinetics PRVB Provention Bio PHVS Pharvaris BV ALDX Aldeyra The IMCR Immunocore Holdings Ltd KDNY Chinook Therapeutics IONS Ionis Pharmaceuticals ALPN Alpine Immune Sciences AN AutoNation KD Kyndryl Holdings VERA Vera Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Raghuram Selvaraju (HC WAINWRIGHT)